Collegium to Participate in Upcoming Investor Conferences

About this update from Collegium Pharmaceutical, Inc.

STOUGHTON, Mass. , Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences: Jefferies London Healthcare Conference Presentation Date and Time: Wednesday, November 19, 2025 , at 8:00 a.m. GMT London, UK The presentation will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com . A replay of the webcast will be archived on the Company's website for 90 days following the presentation. Piper Sandler 37th Annual Healthcare Conference Fireside Chat Date and Time: Tuesday, December 2, 2025 , at 2:30 p.m. ET New York, NY The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com . A replay of the webcast will be archived on the Company's website for 90 days following the presentation. Evercore Healthcare Conference Thursday, December 4, 2025 Coral Gables, FL About Collegium Pharmaceutical, Inc. Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and a rapidly growing neuropsychiatry business driven by Jornay PM®, a differentiated treatment for ADHD. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts . For more information, please visit the Company’s website at www.collegiumpharma.com . Investor Contacts: Ian Karp Head of Investor Relations [email protected] Danielle Jesse Director, Investor Relations [email protected] Media Contact: Cheryl Wheeler Head of Corporate Communications [email protected] Source: Collegium Pharmaceutical, Inc.

View stock analysis, news, and events for Collegium Pharmaceutical, Inc.